ArticleJournal of thoracic disease2026
Global trends and research progress on immunotherapy for
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Research progress and trends on DNA methylation research in non-small cell lung cancer: a bibliometric analysis.Journal of thoracic disease · 2026Article
- Course of Step Counts During Systemic Treatment for Non-small Cell Lung Cancer-Observational Data from a Prematurely Terminated Prospective Study.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immunotherapy for epidermal growth factor receptor ( Methods: The Web of Science Core Collection was searched to identify relevant articles published from 1995 to 2024. Using a combination of bibliometric tools including VOSviewer, CiteSpace, and "bibliometrix" package of R, we analyzed publication trends, citation patterns, collaborative networks, and keyword frequencies. Results: The analysis encompassed 1,537 publications from 352 sources, involving 12,131 authors. China led in publication volume, while the USA demonstrated the highest citation impact and strongest international collaboration network. Harvard University topped institutional output, but Dana Farber Cancer Institute showed the highest citation impact. The Conclusions: This study's bibliometric analysis of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.